baber/WOPTO huggingface dataset:
Patent AU-2006246975-B2 (AU)
Title: Sequential cloning system
Inventor: FRANK KOENTGEN
IPC: C12N15/65
Filed: 2006-05-17
Granted: 2011-08-11
Abstract: This invention discloses a cloning system and more particularly a system for sequentially cloning a plurality of heterologous nucleic acid sequences to assemble a chimeric construct of interest. The cloning system employs a marker sequence, which confers an identifiable characteristic on host cells in which it is contained, to chaperone individual insert nucleic acid sequences into recipient constructs that do not comprise the marker sequence but comprise other nucleic acid sequences for inclusion in the chimeric construct. Recombinant constructs into which one or more insert nucleic acid sequences have been introduced with the chaperone marker sequence are isolated by introducing recombinant constructs into host cells and identifying hosts cells with the identifiable characteristic.
Patent AU-2006266391-B2 (AU)
Title: Mold charge delivery
Inventor: MATTICE DANIEL L
IPC: B29C43/08
Filed: 2006-06-05
Granted: 2011-01-27
Abstract: An apparatus for placing a mold charge into a cavity includes a pair of hubs mounted for rotation around parallel axes, a link connected between the hubs at positions off-center relative to the parallel axes and a blade connected to the link. Rotation of the hubs causes the blade to travel in an elliptical path relative to an extrusion orifice to cut mold charges from the orifice and place the mold charges into cavities passing beneath the blade. The apparatus preferably includes a drive member that simultaneously rotates both of the hubs to drive the blade relative to the extrusion orifice and cavities. The blade preferably includes an arm that extends into a cavity to place a mold charge into the bottom of the cavity for consistent and accurate placement of the mold charges from one cavity to the next.
Patent AU-2006271680-B2 (AU)
Title: Toughened compositon
Inventor: MEUNIER CELINE
IPC: C08L53/00
Filed: 2006-07-14
Granted: 2012-02-02
Abstract: The instant invention relates to epoxy resin compositions comprising an epoxy resin, a block copolymer having at least one block predominantly composed of methyl methacrylate units or a core shell component and a hardener of the polyoxyalkyleneamine type. The epoxy materials cured from these compositions have high impact resistance.
Patent AU-2006278119-B2 (AU)
Title: Storage stable solutions of optical brighteners
Inventor: MAHON MARGARET
IPC: C07D251/68
Filed: 2006-07-12
Granted: 2012-04-05
Abstract: The instant invention relates to storage stable solutions of optical brighteners based on certain salt forms of anilino- substituted bistriazinyl derivatives of 4,4 ' -diaminostilbene-2, 2 ' -disulphonic acid of formula (I) wherein R , R , R , M and n are as defined in the description, which do not need extra solubilising additives.
Patent AU-2006290416-B2 (AU)
Title: An improved process for the preparation of beta-lactam antibiotic
Inventor: KARALE SANJAY NIVRUTI
IPC: C07D477/20
Filed: 2006-09-15
Granted: 2012-04-12
Abstract: The present invention relates to a process for the preparation of Meropenem of formula (I) in sterile form and also provides an improved process for the preparation of compound of formula (V), which is an important intermediate in the synthesis of Meropenem.
Patent AU-2006293812-B2 (AU)
Title: Improved method for making ethyl esters from natural fats
Inventor: BRUNO DELFORT
IPC: C07C67/03
Filed: 2006-09-19
Granted: 2011-12-15
Abstract: The invention concerns a method for obtaining quasi-quantitative fatty acid ethyl esters useful as diesel oil substitutes, from natural, vegetable or animal, oils or fats, or other mixtures of glycerides, including the following successive steps: a step (a) which consists in transesterifying the oil, fat or the mixture of glycerides with ethanol using a soluble catalyst, or a catalyst becoming soluble during the reaction; a step (b) which consists in decanting and eliminating the formed glycerin, without resorting to evaporation of excess ethanol; a step (c) which consists in performing a second transesterification reaction to obtain a product whereof the ester content is at least 97 wt. %; a step (d) which consists in controlled neutralizing of the catalyst; a step (e) which consists in eliminating by distillation excess ethanol; a step (f) which consists in purifying the ester by washing sequences with water; and a step (g) which consists in drying the mixture of ester under reduced pressure.
Patent AU-2006308796-B2 (AU)
Title: Hollow bar manufacturing process
Inventor: TOM WILSON
IPC: B21B17/14
Filed: 2006-11-01
Granted: 2011-09-29
Abstract: A process for forming a relatively thick-walled hollow bar by hot rolling an elongate member comprises the steps: (i) in at least one pass, rolling the elongate member so as to generally define at least two longitudinally extending portions of the hollow bar; (ii) in at least one pass, bending the resultant rolled member from (i) so as to bring outer edges of the elongate member into proximity with each other. After step (i) the resultant portions are interconnected at a longitudinal region of bar material that is formed so as not to act as a hinge during bending step (ii).
Patent AU-2007200603-B2 (AU)
Title: Airflow control mechanism
Inventor: BARRY PEARS
IPC: A47L9/00
Filed: 2007-02-12
Granted: 2011-09-22
Abstract: The present invention provides an airflow control mechanism comprising a conduit for air having an inlet located at a first end thereof and an outlet located at a second end thereof; a first opening formed in a side of said conduit and able to provide a secondary inlet thereto; a movable collar at least partially surrounding said 5 conduit at a location alignable with said first opening, such that said collar is able to at least partially occlude said first opening; further comprising a second opening beside the first opening as part of the secondary inlet, wherein the collar is also alignable with the second opening, such that the collar is able to at least partially occlude the second opening at the same time as the first opening. Thus with this 10 airflow control mechanism, a user may select whether to occlude both the first and the second openings, in which case air will pass directly from the inlet to the outlet without any air also entering through the secondary inlet, or to occlude neither the first and second openings, in which case air entering the secondary inlet will contribute to the total amount of air exiting the outlet, or to occlude just one of the first 15 and second openings, in which case, a fixed amount of air which is less than the secondary inlet being fully open, but more than the secondary inlet being fully closed, will enter through the secondary inlet and contribute to the total amount of air exiting the outlet. Thus the user will be provided with a highly predictable and repeatable setting for the airflow control mechanism between the fully open and fully closed 20 positions of the secondary inlet. [Fig. 2A]
Patent AU-2007241111-B2 (AU)
Title: Adhesion-promoting compositions and methods of promoting adhesion between a coating and a substrate
Inventor: WILT TRUMAN F
IPC: C08G85/00
Filed: 2007-03-29
Granted: 2011-06-23
Abstract: Compositions comprising the reaction product of a polymer comprising a polyol, a polyisocyanate and/or a polyamine and a compound comprising a chlorendate group are disclosed. Also disclosed are methods of improving adhesion between a coating composition and a substrate by applying the adhesion promoting compositions of the present invention to the substrate.
Patent AU-2007243268-B2 (AU)
Title: Coatings containing multiple drugs
Inventor: COLE MIKE
IPC: A61F2/00
Filed: 2007-04-26
Granted: 2013-06-13
Abstract: A method for depositing a coating comprising a polymer and at least two pharmaceutical agents on a substrate, comprising the following steps: providing a stent framework; depositing on said stent framework a first layer comprising a first pharmaceutical agent; depositing a second layer comprising a second pharmaceutical agent; Wherein said first and second pharmaceutical agents are selected from two different classes of pharmaceutical agents.
Patent AU-2007308950-B2 (AU)
Title: Method for creating and analyzing advertisements
Inventor: YOUNG CHARLES
IPC: G06Q90/00
Filed: 2007-10-24
Granted: 2012-05-17
Abstract: A method for analyzing advertisements and advertising campaigns. Important images are selected from one or more advertisements and then ranked. The most important images are then assigned to a category which preferably corresponds to a memory type, such as knowledge, emotion, or action. The relative numbers of images in each type determine the focus of the advertisement(s), and may be used to tailor the memory type(s) of subsequent advertisements.
Patent AU-2007334023-B2 (AU)
Title: A hologram appearing package image
Inventor: SARNATARO JOHN A
IPC: B41M3/00
Filed: 2007-12-13
Granted: 2011-09-15
Abstract: A package that has at least one hologram on its exterior surface is formed from a paper, paperboard or thermoplastic substrate material that has an inner surface and an outer surface. The outer surface has a radiation curable particulate metal containing coating. This coating is cured and zero to one or more ink containing coatings are applied to the radiation curable particulate metal containing coating in areas that are not to have a hologram. Each of these ink containing coatings are cured, and a substantially transparent radiation curable coating is applied to the areas deficient in the zero to one or more ink coatings. This substantially transparent radiation curable coating is contacted with a substantially transparent holographic shim in an area not having thereon ink containing coatings while curing radiation is applied to the substantially transparent radiation curable coating and the substantially transparent shim.
Patent AU-2008201784-B2 (AU)
Title: Cooled helical antenna for microwave ablation
Inventor: ROSSETTO FRANCESCA
IPC: H01Q1/38
Filed: 2008-04-23
Granted: 2012-01-19
Abstract: COOLED HELICAL ANTENNA FOR MICROWAVE ABLATION Abstract A microwave antenna assembly (10) including an elongated cooling jacket (28) having proximal and distal ends and an inner lumen defined therebetween and a helical 5 microwave antenna member (16) disposed within at least a portion of the elongated cooling jacket (28) and having an inner and outer conductor (24, 26), the inner conductor (24) disposed within the outer conductor (26), wherein at least a portion of the inner conductor (24) extends distally from the outer conductor (26) and forms at least one loop; and wherein the inner conductor (24) is configured to deliver microwave energy. 10> 25-\ 26-,z 28- 36 18--, 38 <32 2 2- - - **** * -0 -- -------------- -*- -*---A 24 30 36 1616a 128 136 133 129 138 132 116a 126-, 124-\ 125-\ 116 122-, 1*-\-,* T$$ xi, D S 1 16a -- L
Patent AU-2008204566-B2 (AU)
Title: Novel mesenchymal progenitor cells derived from human blastocyst-derived stem cells
Inventor: STREHL RAIMUND
IPC: C12N5/0775
Filed: 2008-01-11
Granted: 2014-03-13
Abstract: The present invention relates to a novel mesenchymal human progenitor (hBS- MP) cell population derived from human blastocyst-derived stem (hBS) cells and the method to obtain the progenitor cell population in which is eliminated the need of co-culture steps, cell sorting, manual selection, and transfections. Furthermore, the present invention relates to the use of the hBS-MP cells in drug discovery and specifically for toxicity testings as well as for therapeutic use.
Patent AU-2008206205-B2 (AU)
Title: Artificial functional spinal unit system and method for use
Inventor: LANDRY MICHAEL E
IPC: A61B17/70
Filed: 2008-01-17
Granted: 2013-06-06
Abstract: A stabilization system for a human spine is provided. The stabilization system may include one or more dynamic interbody devices and/or one or more dynamic posterior stabilization systems. The dynamic interbody devices may provide for coupled axial rotation and lateral bending of vertebrae adjacent to the dynamic interbody devices. The dynamic posterior stabilization systems may provide resistance to movement that mimics the resistance provided by a normal functional spinal unit.
Patent AU-2008240341-B2 (AU)
Title: System and methods for performing percutaneous pedicle integrity assessments
Inventor: MARTINELLI SCOT
IPC: A61B5/11
Filed: 2008-10-31
Granted: 2012-04-05
Abstract: The present invention involves systems (20) and related methods for performing percutaneous pedicle integrity assessments involving the use of 5 neurophysiology. The fundamental method steps for performing the percutaneous pedicle integrity assessments include (a) percutaneously introducing an insulation member to a pedicle target site; (b) establishing electrical communication between a stimulation element and an interior of a pedicle screw pilot hole; (c) applying a stimulation signal to the stimulation 10 element; and (d) monitoring to assess whether nerves adjacent the pedicle are innervating as a result of the step of applying the stimulation signal to the stimulation element.
Patent AU-2008246754-B2 (AU)
Title: Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same
Inventor: YAMAMOTO EIICHI
IPC: A61P31/10
Filed: 2008-04-23
Granted: 2012-07-12
Abstract: An antifungal agent that has an excellent antifungal activity and excels in not only properties, especially solubility in water but also safety. There are disclosed compounds of the formula (I) and salts thereof. [in the formula, R is a hydrogen atom, halogen atom, amino, R-NH- (R is a C-C alkyl, hydroxylated C-C alkyl, C-C alkoxylated C-C alkyl or C-C alkoxycarbonylated C-C alkyl), R-(CO)-NH- (R is a C-C alkyl or C-C alkoxylated C-C alkyl), C-C alkyl, hydroxylated C-C alkyl, cyano C-C alkyl, C-C alkoxy, C-C alkoxylated C-C alkyl or phosphonoamino; R is a hydrogen atom, C-C alkyl, amino, di-(C-C alkylamino) or phosphonoamino; either X or Y is a nitrogen atom while the other is a nitrogen atom or oxygen atom; the ring A is a 5- or 6-membered heteroaryl ring or benzene ring optionally having one or two C-C alkyls or halogen atoms; Z is a single bond, methylene,ethylene, oxygen atom, sulfur atom, -CHO-, -OCH-, -NH-, -CHNH-, -NHCH-, -CHS- or -SCH-; R is a hydrogen atom, halogen atom, or optionally monosubstituted or disubstituted C-C alkyl, C-C cycloalkyl, C-C aryl, 5- or 6-membered heteroaryl or 5- or 6-membered nonaromatic heterocycle; and R is a hydrogen atom or halogen atom, provided that either R or R is phosphonoamino].
Patent AU-2008254578-B2 (AU)
Title: Novel rabbit antibody humanization methods and humanized rabbit antibodies
Inventor: KOVACEVICH BRIAN
IPC: C07K16/00
Filed: 2008-05-21
Granted: 2013-06-06
Abstract: The present invention is directed to novel and improved methods for humanizing rabbit heavy and light variable regions. The resulting humanized rabbit heavy and light chains and antibodies and antibody fragments containing are well suited for use in immunotherapy and immunodiagnosis as they retain the antigen binding affinity of the parent antibody and based on their very high level of sequence identity to human antibody sequences should be essentially non-immunogenic in humans. The invention exemplifies the protocol for the manufacture of therapeutic humanized anti-human TNF-alpha and anti-human IL-6 antibodies.
Patent AU-2008258099-B2 (AU)
Title: Personal care composition with cocoa butter and dihydroxypropyl ammonium salts
Inventor: TIAN WEI DONG
IPC: A61Q19/00
Filed: 2008-01-21
Granted: 2010-12-02
Abstract: A personal care composition is provided that when the composition is applied to the skin provides improved translucency to reveal a healthy skin color. The composition is based upon a mixture of dihydroxypropyl quaternary ammonium salt and cocoa butter.
Patent AU-2008267158-B2 (AU)
Title: Distributor power line communication system
Inventor: HENDERIECKX LUC
IPC: H04B3/54
Filed: 2008-06-25
Granted: 2013-06-27
Abstract: Distributor power line communication system comprising a communication server (1 ) sending and receiving messages over a telecommunication network (2), a power distribution substation (3) to which a power distribution network (4) towards end users (5) is connected, at least one gateway (6; 18) transferring messages from the telecommunication network (2) onto the power distribution network (4) in a predetermined frequency band, a plurality of smart metering devices (7; 17; 27) at end user mains networks for measuring power consumption and comprising a power line communication modem (8; 18) sending and receiving messages within the predetermined frequency band over the power distribution network (4), power line communication filters (10, 11 ) on power lines connecting the power distribution network and the end user mains networks and on power lines connecting the power distribution network to the power distribution substation, each filter blocking frequencies within the predetermined frequency band.
Patent AU-2008277350-B2 (AU)
Title: Preprocalcitonin antigen T epitopes
Inventor: MAMI-CHOUAIB FATHIA
IPC: C07K14/585
Filed: 2008-06-19
Granted: 2013-08-22
Abstract: The present invention is related to Preprocalcitonin antigen T epitopes, presented by the Major Histocompatibility Complex I (MHC I). These peptides can be used in cancer immunotherapy.
Patent AU-2008279362-B2 (AU)
Title: Floor finish applicator
Inventor: CONNER CRAIG P
IPC: A47L11/24
Filed: 2008-07-17
Granted: 2012-12-20
Abstract: A pull-behind floor finish applicator wherein a peristaltic pump is employed in conjunction with disposable conduit tubing obviate any clean up of the pump. This applicator is adaptable to receiving bag in the box floor finish, thus reducing cleaning time. The applicator employs a minimum number of disposable parts thus making it economical to produce. A mop is employed to apply floor finish to easily accessible areas in one instance, yet allows the mop to be used independently for application of floor finish to not so easily accessible areas.
Patent AU-2008280485-B2 (AU)
Title: Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
Inventor: NICOLE DUWELHENKE
IPC: A61K38/08
Filed: 2008-07-23
Granted: 2011-09-15
Abstract: The invention relates to the use of a pharmaceutical composition for the local treatment or prevention of a tissue infection at an infection site, the pharmaceutical composition comprising at least two different antibiotics of group A or pharmaceutically acceptable derivatives thereof, or an antibiotic of group A and at least one antibiotic of group B or pharmaceutically acceptable derivatives thereof. Group A comprises primarily intracellular active antibiotics working as inhibitor of bacterial RNA polymerase; as inhibitor of gyrase; or as inhibitor of bacterial protein synthesis. Group B comprises primarily extracellular active antibiotics working as inhibitor of bacterial cell wall synthesis; or inhibitor of bacterial protein synthesis; or by direct destabilisation or rupture of the bacterial cell wall. The invention further relates to a pharmaceutical composition for treatment of extracellular and/or intracellular microbial infected cells and/or for the prevention of microbial cell infections comprising at least one antibiotic acting as an inhibitor of bacterial RNA polymerase and/or at least one antibiotic affecting the bacterial cell wall or its synthesis, and a substrate carrying a pharmaceutical composition. The invention also relates to the use of a combination of at least one antibiotic acting as an inhibitor of bacterial RNA polymerase and at least one antibiotic affecting the bacterial cell wall or its synthesis as anti-adhesive against microorganisms on surfaces.
Patent AU-2008286027-B2 (AU)
Title: Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
Inventor: AMARI GABRIELE
IPC: A61K31/44
Filed: 2008-07-17
Granted: 2013-02-21
Abstract: The invention relates to inhibitors of the phosphodiesterase 4 (PDE4) enzyme. More particularly, the invention relates to compounds that are derivatives of 1-phenyl-2-pyridinyl alkyl alcohols, methods of preparing such compounds, compositions containing them and therapeutic use thereof.
Patent AU-2008337954-B2 (AU)
Title: Controllable air channels for feeding additional combustion air into the area of flue gas channels of coking chamber furnaces
Inventor: RONALD KIM
IPC: C10B15/02
Filed: 2008-12-04
Granted: 2014-02-20
Abstract: The invention relates to a device for feeding and controlling secondary air from secondary air channels into flue gas channels of horizontal coking chamber ovens. The flue gas channels are thereby located under the coking chamber floor on which coking takes place. The flue gas channels serve for combusting partially combusted coking gases from the coking chamber. The partially combusted coking gases are combusted using secondary air, whereby the coke cake is also heated from below for uniform coking. The secondary air comes from the secondary air channels connected to outside air and to the flue gas channels. Control elements are installed in the connection channels between the flue gas channels and the secondary air channels and can precisely control the air flow in the flue gas channels. Significantly more uniform heating and heat distribution can thus be achieved in coking chamber furnaces. The actual control devices in the connecting channels can be formed by rotatable tube segments, bricks, or metal dampers. A stool-like device can also be used particularly advantageously, said device sitting in the secondary channels and having a hump plate having a central opening slid under the corresponding branch for controlling the gas flow. The control mechanism can be manually, electrically, or pneumatically actuated. The control device can thereby also be automated.
Patent AU-2008339985-B2 (AU)
Title: Mammalian expression vector
Inventor: WILMS BURKHARD
IPC: C12N15/79
Filed: 2008-12-18
Granted: 2012-03-01
Abstract: The invention provides vector nucleic acid for expressing at least one polypeptide of interest in a mammalian cell, comprising (a) at least one expression cassette (POI) for expressing a polypeptide of interest; (b) an expression cassette (MSM) comprising a mammalian selectable marker gene; (c) an expression cassette (MASM) comprising a mammalian amplifiable, selectable marker gene; wherein the expression cassette (POI) is flanked 5' by the expression cassette (MASM), the expression cassette (MSM) is located 3' from the expression cassette (POI) and wherein the expression cassettes (MASM), (POI) and (MSM) are arranged in the same 5' to 3' orientation. Also provided are host cells, comprising said vector and methods for producing a polypeptide using respective host cells.
Patent AU-2009227977-B2 (AU)
Title: Prospect stress prediction
Inventor: DAVIDSON JOHN KENNETH
IPC: G01V1/28
Filed: 2009-03-25
Granted: 2014-05-15
Abstract: A method is provided for obtaining a quantitative prediction of a magnitude of a maximum horizontal stress (S
Patent AU-2009231774-B2 (AU)
Title: Method and apparatus for supporting emergency calls (eCalls)
Inventor: SUBRAMANIAN RAMACHANDRAN
IPC: H04W4/90
Filed: 2009-04-01
Granted: 2012-08-30
Abstract: Techniques for supporting eCalls are described. In an aspect, an eCall indicator may be used to indicate an eCall being established. In one design, a terminal may generate a message including an eCall indicator and may send the message to originate an eCall. The eCall indicator may indicate (i) whether or not a call is an eCall or (ii) whether an eCall is initiated automatically by the terminal or manually by a user. In another aspect, a terminal may avoid sending signaling for mobility management and connection management to wireless networks except for eCalls and designated calls. The terminal may avoid performing location updating, performing registration, responding to paging requests, etc. The terminal may exchange signaling with a wireless network for an eCall initiated by the terminal. After the eCall is initiated, the terminal may perform location updating with the wireless network and call establishment for the eCall.